Next Generation Sequencing Technologies - Impact on Microbial Genomics

The next generation sequencing is a matured market in the developing countries as well as developing economies worldwide. The necessity of genetic analysis is constantly increasing in recent days due to the reliable and accurate results being offered by the technique. The demand for next generation sequencing is experienced mostly from academic institutions followed by hospitals & clinics.

Download PDF Brochure of Study, Click Here @ https://www.theinsightpartners.com/sample/TIPHE100000820/?utm_source=opr%2F10291

The Next Generation Sequencing Market in across the globe includes PerkinElmer, Inc., Oxford Nanopore Technologies, Ltd., Beijing Genomics Institute, Macrogen, Inc., F. Hoffmann-La Roche AG, Agilent Technologies, Eurofins Scientific, Qiagen N.V., Thermo Fisher Scientific, and Illumina, Inc. among others.

Cancer can be cured if diagnosed and treated at an initial stage. Cancer sequencing using next-generation sequencing (NGS) methods provides more information. Additionally, NGS also aids in diagnostics and treatment of cancer. In recent years, the cases of cancer has been increasing tremendously and the trend is anticipated to remain the same in the upcoming years. Due to preference of better technologies for detection of fatal disease, the demand for next generation sequencing is anticipated to witness constant growth in the upcoming years.

Modification and automation of this process continued to increase sequencing data and time reduction. Thereby allowing researchers to reach major milestones in the Human Genome Project. NGS makes sequence based gene expression analysis a "digital? alternative to analog techniques. It also aids in quantifying RNA expression with the breadth of a microarray and the resolution of qPCR. Advancement in genome sequencing has made the sequencing easy and accurate. These technological advancement are likely to grow the market in near future.

Industry Insights of Next Generation Sequencing:

Declining Price of Sequencing:

In recent years, the next generation sequencing price has declined substantially. For instance, the first whole human genome sequencing cost above US$3.7 billion in 2000 and took 13 years for fulfillment. However, the costs for the same in recent years have reduced to US$ 1,000, and the process needs fewer days. In 2000, the price for sequencing was US$ 3.7 billion, which fell to US$ 10 million in 2006 and reduced to US$ 5,000 in 2012. Significant companies such as Illumina and Roche have launched advanced technologies that have allowed in the cost and time reduction in the sequencing. Owing to factors such as advancement in the field of genomics, development in different methods and strategies for sequencing, a notable decline in the cost of sequencing.

Product Insights

The next generation sequencing market based on product is segmented into consumables, services, and platforms. In 2017, the consumables segment held the most significant market share of the next generation sequencing, by product. The segment is further anticipated to command the market in 2025 by product as the consumers widely accept the consumables offered by various companies, and it provides accuracy and precision in the preparation of the NGS. Moreover, the consumers segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

Technology Insights

The next generation sequencing market on the basis of technology is segmented into genome sequencing, exome sequencing, resequencing & targeted sequencing and others. In 2017, the resequencing & targeted sequencing segment held a largest market share of the next generation sequencing market, by technology. Furthermore, the resequencing & targeted sequencing segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

The global next generation sequencing market is a matured market in the developing countries as well as developing economies worldwide. The necessity of genetic analysis is constantly increasing in recent days due to the reliable and accurate results being offered by the technique. The demand for next generation sequencing is experienced mostly from academic institutions followed by hospitals & clinics.

Among the applications, the demand for next generation sequencing is significantly high in diagnostics, drug discovery, followed by precision medicine. Furthermore, advancements in sequencing technologies and declining cost of sequencing is expected to be a driving factor for the next generation market.

Modification and automation of this process continued to increase sequencing data and time reduction. Thereby allowing researchers to reach major milestones in the Human Genome Project. NGS makes sequence based gene expression analysis a "digital? alternative to analog techniques. It also aids in quantifying RNA expression with the breadth of a microarray and the resolution of qPCR. Advancement in genome sequencing has made the sequencing easy and accurate. These technological advancement are likely to grow the market in near future.

Regional Outlook for Next Generation Sequencing:

The market for next generation sequencing is well established in the region of North America, owing to the awareness regarding medical practices and technological developments in the process of next generation technology. Various market players have been focusing towards shifting their customer base in North America. For instance, Illumina, Inc. along with Telegraph, established a company called Verogen. The company would be entitled to provide Illumina's forensic products to the customers in the US.

Want to Know More about Next Generation Sequencing..?

Get More Information with PDF Sample Copy @ https://www.theinsightpartners.com/buy/TIPHE100000820/?utm_source=opr%2F10291

Contact Us

Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.